[Arrhythmogenic action of anti-arrhythmia agents. Current clinical view of pro-arrhythmias]
Related Experiment Video
Updated: Oct 23, 2026

Isolation of Human Atrial Myocytes for Simultaneous Measurements of Ca2+ Transients and Membrane Currents
Published on: July 3, 2013
T Fazekas1, J L Smeets, H J Wellens
1Szent-Györgyi Albert Orvostudományi Egyetem, Szeged.
Abstract:
Recent knowledge relating to the proarrhythmic actions of antiarrhythmics is reviewed. After establishing the diagnostic criteria the authors discuss the incidence of proarrhythmias illustrating the wide spectrum of "drug-induced arrhythmogenesis" with clinical examples. The possibilities of recognition, prediction and prevention of proarrhythmic events and sudden death are outlined.
More Related Videos
Related Concept Videos
Mechanism of Cardiac Arrhythmias
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Disturbances in Heart Rhythm
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...

